News | June 08, 2022
Halozyme announces commercial launch of testosterone undecanoate 'TLANDO'
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The company has posted net profit of Rs.165.66 crores for the Financial Year ended March 31, 2022
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The drug will be manufactured at the group’s topical facility at Ahmedabad
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
Innate to receive $5M milestone payment from AstraZeneca
Subscribe To Our Newsletter & Stay Updated
